|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 9/14 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| C07D 235/06 | (2006.01) |
| (11) | Number of the document | 2271321 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09726304.0 |
| Date of filing the European patent application | 2009-03-26 | |
| (97) | Date of publication of the European application | 2011-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2012-06-13 |
| (46) | Date of publication of the claims translation | 2012-10-25 |
| (86) | Number | PCT/GB2009/050293 |
| Date | 2009-03-26 |
| (87) | Number | WO 2009/118562 |
| Date | 2009-10-01 |
| (30) | Number | Date | Country code |
| 40372 | 2008-03-28 | US |
| (72) |
BATEMAN, Nicola, Frances, GB
GELLERT, Paul, Richard, GB
HILL, Kathryn, Jane, GB
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
AstraZeneca AB, 151 85 Södertälje, SE |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Farmacinė kompozicija 271 |
| PHARMACEUTICAL COMPOSITION 271 |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 18 | 347.00 EUR |
| 2027-03-26 |